Tesamorelin 15MG
$185.00
Tesamorelin 15MG is a 15-milligram format of tesamorelin, a synthetic analogue of growth hormone releasing hormone (GHRH). Researchers study tesamorelin in endocrine and metabolic research where pulsatile growth hormone signaling is of interest. Studies have also examined this peptide in models focused on IGF 1 related pathways and body composition endpoints.
In Stock
Tesamorelin 15MG is a 15-milligram format of tesamorelin, a synthetic growth hormone releasing hormone (GHRH) analogue peptide. It is designed as a stabilized GHRH sequence and is widely referenced in research exploring hypothalamic pituitary somatotropic signaling.
Researchers study Tesamorelin 15MG in contexts where growth hormone pulse dynamics, downstream IGF 1 biomarkers, and metabolic endpoints are being investigated. Preclinical and clinical studies have examined tesamorelin using endocrine measurements and body composition related readouts, though findings vary by model and study design.
- Specification: 15MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
SS-31 50MG is a 50-milligram format of SS-31, a synthetic tetrapeptide also known as elamipretide. Researchers study SS-31 for its potential to localize to mitochondria and for its use in preclinical models examining mitochondrial membrane and bioenergetic pathways.
In Stock
Testosterone Base – 100mg/ml, 10 is a 100 mg/mL format of testosterone, the primary endogenous androgen and anabolic steroid hormone in humans. Researchers study testosterone in models of androgen receptor signaling, steroidogenesis, and endocrine regulation. It is also used as a reference standard in analytical chemistry and bioassay method development.
In Stock
CJC 1295 With DAC 5MG is a 5-milligram format of CJC-1295 with drug affinity complex (DAC), a synthetic growth hormone releasing hormone analogue peptide. Researchers study this modified GHRH fragment for its potential to extend peptide half life through albumin binding. Studies have examined CJC 1295 With DAC 5MG in preclinical and investigational settings focused on pulsatile GH signaling and IGF 1 related endpoints.
In Stock
GHK-Cu 50MG is a 50-milligram format of copper peptide GHK-Cu, a coordination complex formed by the tripeptide glycyl-L-histidyl-L-lysine bound to Cu2+. Researchers study GHK-Cu in models involving skin biology, extracellular matrix signaling, and wound related pathways.
In Stock
MOTS-C 40MG is a 40-milligram format of MOTS-c, a 16 amino acid mitochondrial derived peptide encoded within mitochondrial 12S rRNA. Researchers study MOTS-c for its potential role in cellular stress responses and metabolic signaling in preclinical models. Interest also includes how this peptide may interact with exercise related pathways and adaptive physiology.
In Stock
Glutathione 1500MG is a 1500-milligram format of glutathione, a naturally occurring tripeptide made of glutamate, cysteine, and glycine. Researchers study glutathione in the context of cellular redox balance and antioxidant systems. It is also investigated in models involving detoxification pathways and oxidative stress biology.
In Stock
Glutathione 1200MG is a 1200-milligram format of glutathione, a naturally occurring tripeptide composed of glutamate, cysteine, and glycine. Researchers study glutathione in redox biology and oxidative stress models, including pathways involved in cellular detoxification and antioxidant cycling.
In Stock
BPC-157 + GHK-GHK-Cu + TB-500 50MG is a 50-milligram combination format bringing together three widely studied research peptides used in preclinical recovery and tissue-model work. Researchers investigate BPC-157, a 15 amino acid peptide fragment, alongside the copper binding GHK tripeptide motif and TB-500, a thymosin beta 4 analogue fragment, in models involving connective tissue, angiogenesis signaling, and cellular migration pathways.
In Stock
BPC-157 + GHK-GHK-Cu + TB-500 70MG is a 70-milligram combination format of three commonly studied research peptides: BPC-157, GHK-Cu, and TB-500. Researchers investigate these peptides in preclinical work involving connective tissue biology, angiogenesis signaling, and recovery related pathways. The blend is used in experimental designs where multiple peptide classes are evaluated together under controlled laboratory conditions.
In Stock
Ripex-225 225mg/ml, 10 ml is a research compound supplied in a defined concentration and volume format. Researchers may reference Ripex-225 in analytical, stability, or method development work where consistent concentration labeling is required. This product is intended for laboratory workflows that document concentration and total volume as primary identifiers.
In Stock
CJC 1295 Without DAC 10MG | GHRH 1 29 Peptide Analogue is a 10 mg format of the short GHRH 1 to 29 analogue commonly referred to as Mod GRF 1 to 29. Researchers study this peptide in laboratory work focused on growth hormone signaling models and pulsatile release dynamics. It is frequently used as a reference compound in peptide endocrinology research.
In Stock
Trestolone Acetate (Ment) 50mg ml 10ml is a specified format of trestolone acetate, a synthetic 19 nor androgen and anabolic steroid ester. Researchers study MENT in endocrinology and androgen receptor focused models, including comparisons to testosterone derived compounds. Work has also examined trestolone in the context of gonadotropin regulation and progestogenic activity using preclinical and in vitro methods.
In Stock
